ethyl pyruvate has been researched along with Adenocarcinoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beer-Stolz, D; Davé, SH; DeMarco, RA; Fink, MP; Li, F; Lotze, MT; Matsuoka, K; Plevy, SE; Sepulveda, AR; Tilstra, JS | 1 |
| Chen, NW; Chen, WX; Zhang, J; Zhou, Z; Zhu, JS | 1 |
| Choi, JE; Duong, HQ; Han, SI; Jeong, GA; Kang, HS; Kim, CH; Lim, SC | 1 |
3 other study(ies) available for ethyl pyruvate and Adenocarcinoma
| Article | Year |
|---|---|
Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis.
Topics: Adenocarcinoma; Animals; Annexin A5; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colitis; Colonic Neoplasms; Cytokines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorescein-5-isothiocyanate; HMGB1 Protein; In Situ Nick-End Labeling; Interleukin-10; Interleukin-12 Subunit p40; Intestinal Mucosa; Liver Neoplasms; Mice; Mice, Inbred C57BL; Mice, Knockout; Microtubule-Associated Proteins; Neoplasm Metastasis; Neoplasm Transplantation; Nitric Oxide; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Pyruvates; Random Allocation; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Transfection | 2009 |
Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; HMGB1 Protein; Humans; Mice; Mice, Inbred BALB C; Neoplasm Grading; Proto-Oncogene Proteins c-akt; Pyruvates; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Signal Transduction; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2012 |
Ethyl pyruvate induces necrosis-to-apoptosis switch and inhibits high mobility group box protein 1 release in A549 lung adenocarcinoma cells.
Topics: Adenocarcinoma; Apoptosis; Glucose; HMGB1 Protein; Humans; Inflammation; Lung Neoplasms; Necrosis; Pyruvates; Reactive Oxygen Species; Superoxide Dismutase; Tumor Cells, Cultured | 2007 |